Coadministration of Oral Levofloxacin With Agents That Impair Absorption: Impact on Antibiotic Resistance •

Divisions of Infectious Diseases, Departments of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Infection Control and Hospital Epidemiology (Impact Factor: 3.94). 11/2008; 29(10):975-7. DOI: 10.1086/590666
Source: PubMed

ABSTRACT Coadministration of oral divalent or trivalent cation-containing compounds with oral fluoroquinolones may impair fluoroquinolone absorption. Among 3,134 patients who received a course of oral levofloxacin, coadministration was significantly associated with subsequent identification of a levofloxacin-resistant isolate. Strategies to curb the emergence of fluoroquinolone resistance should include avoiding the coadministration of divalent or trivalent cation-containing compounds and fluoroquinolone.

Download full-text


Available from: Leanne B Gasink, Apr 22, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: A drug interaction is a situation in which a drug, food or other extrinsic and intrinsic factors affect the activity of a medication, i.e. the effects of the medication are increased or decreased, or the combination of substances produces a new effect that neither of them produces on its own. Thereby often the efficacy or toxicity of a medication is changed.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Not Available
    Security Technology, 1989. Proceedings. 1989 International Carnahan Conference on; 02/1989
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.
    Infectious disease clinics of North America 12/2009; 23(4):1027-51, x. DOI:10.1016/j.idc.2009.06.003 · 2.31 Impact Factor
Show more